Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Sema4
5594
Sema4
Health Care
Medical
Technology
Biotechnology
Sema4 is a patientcentered health intelligence company, dedicated to transforming healthcare through datadriven insights.
Suggest edits
Founded
2017
Raised
$121M
Follow us
Featured on
Companies in the same industry
Nuritas
UniQure
molecular assemblies
Sonendo
CanSino Biologics
SuitX
Atlas Biomed
CureWize
Desktop Genetics
Comfort Line
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$121,000,000
Venture capital (Series C) - 2020
BlackRock
Oak HC/FT
Deerfield
+5
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
Pulse 2.0
Sema4 (SMFR) Stock: Why It Fell Over 19% Today
Pulse 2.0
Sema4 Holdings (SMFR) Stock: $3.50 Target And Buy Rating
MedCity News
Sema4 to acquire GeneDx, capturing $200M in private investment
Pulse 2.0
Sema4 Stock (SMFR): Why The Price Jumped
neurons.AI
Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of …
neurons.AI
Sema4 to Participate in Upcoming Investor Conferences
neurons.AI
Sema4 to Participate in Upcoming Investor Conferences
$121,000,000
Venture capital (Series C)
FinSMEs
,
Pulse 2.0
Sema4 Closes $121M Series C Funding; Post-Money Valued at $1 Billion
TechCrunch
Using population health analysis to improve patient care brings Sema4 a $1.1 billion valuation
Xconomy
With New Test, Schadt’s Sema4 Aims to Broaden Scope of Newborn Screening
Health
Xconomy
Sema4, Eric Schadt’s Genomics Startup, Spins Out of Sinai to Raise Cash
Health
